Early promise, and caution, in measles virus cancer therapy

NEW YORK (Reuters Health) - Mayo Clinic researchers stirred excitement on Thursday by saying they had treated a patient's blood cancer with a specially engineered measles virus, but even scientists involved in the work caution the response does not prove they have a cure.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news

Related Links:

(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff
Source: MedPage Today Radiology - Category: Radiology Source Type: news
The measles news continues: an outbreak in New Jersey, continuing outbreaks in Europe, and a mother of a child with cancer pleads with people to get the measles vaccine.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news
The measles news continues: an outbreak in New Jersey, continuing outbreaks in Europe, and a mother of a child with cancer pleads with people to get the measles vaccine.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news
The measles news continues: an outbreak in New Jersey, continuing outbreaks in Europe, and a mother of a child with cancer pleads with people to get the measles vaccine.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news
In this study, we developed a new non-integrating measles virus (MV) vector-based delivery system with F deletion to eliminate cell membrane fusion-associated cytotoxicity. MV vectors transduced genes through MV receptors including CD46 and signaling lymphocyte activation molecule (CD150/SLAM). First, we examined transduction efficiencies of MV vectors and SV vectors in hematopoietic cells by using GFP expression vectors (MV-Gs and SV-Gs). Compared to SV-Gs, our MV-Gs allowed more efficient gene transfer into most hematopoietic cell type including T (3-fold) and B cells (7-fold) (Fig. 1). Furthermore, at the same multiplic...
Source: Blood - Category: Hematology Authors: Tags: 801. Gene Therapy and Transfer: Poster II Source Type: research
Conclusion: In the lowest dose levels tested to date, VSV-IFNβ-NIS has not led to any observed dose limiting toxicity. Dose escalation is ongoing and updated results will be reported.DisclosuresLacy: Celgene: Research Funding. Peng: Vyriad: Equity Ownership. Russell: Vyriad: Equity Ownership. Dueck: Bayer: Employment; Phytogine: Employment; Pfizer: Honoraria. Witzig: Celgene: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding. Dispenzieri: Celgene, Takeda, Prothena, Jannsen, Pfizer, Alnylam, GSK: Research Funding. Gertz: spectrum: Consultancy, Honoraria; Physicians Educa...
Source: Blood - Category: Hematology Authors: Tags: 653. Myeloma: Therapy, excluding Transplantation: Poster II Source Type: research
Beloved Hollywood celebrities, famous politicians or members of the British royal family: no better advertisement for fitness tracker producers and health tech companies. As models, actors and actresses are highly influential people, their early adoption of digital solutions could also push the masses towards living more healthily with technologies. On the other hand, celebrities are inclined to follow questionable health trends, too, which go against decades of medical evidence. Those examples, everyone should rather reject. Wearables conquered Hollywood, the White House, and the British royal family Celebrities are all a...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Social media in Healthcare celebrities digital health digital technologies digital technology famous fitness future health influencer health influencers Hollywood trackers trends wearables wellness Source Type: blogs
Do all medical educators start out by publishing advanced research? Or do some try their hand at something else first? We asked the members of the Academic Medicine editorial board about their first publication. This is what they said. M. Brownell Anderson, National Board of Medical Examiners Except for serving as editor of my high school newspaper, my first publication was: Soler NG, Mast TA, Anderson MB, Kienzler L. A logbook system for monitoring student skills and experiences. J Med Educ. 1981;56:775-777. My first publication as first author was: Anderson MB, Mast TA, Soler NG. A required internal medicine precept...
Source: Academic Medicine Blog - Category: Universities & Medical Training Authors: Tags: Editorial Board Q & A Featured Academic Medicine Anthony R. Artino Jr Brenessa Lindeman Bridget C. O’Brien Carrie L. Byington Christopher S. Candler Colin P. West Denice Cora-Bramble Grace Huang John P. Sánchez M. Brownell Ander Source Type: blogs
As a pharmacist, Kathy James considers herself well educated about the importance of getting regular cancer screenings. Even though the 55-year-old had no history of cancer in her family, she never skipped her regular mammograms, and she gave herself regular breast exams. So she was dumbfounded when, during one of those self-exams in May 2017, she felt a marble-size lump in her left breast. A visit to the doctor confirmed it. “The radiologist came in with his hands in his pockets and looked down and said, ‘It doesn’t look good,'” James says. After a biopsy, James and her husband learned she had meta...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized breast cancer news Frontiers of Medicine Source Type: news
ConclusionsOur study demonstrated that tumor cells expressing H protein could activate the immune memory response against MV, which exerted specific anti-tumor effects, and indicated that the MV-H gene can be used as a potential therapeutic gene for cancer gene therapy.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Health | Measles